Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness. | PLoS Pathog | 2022 | 36399512 | PubTator, text mining | PubMed |
| COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation. | Front Immunol | 2022 | 36389832 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. | Front Immunol | 2022 | 36389712 | PubTator, text mining | PubMed |
| Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β. | Mol Ther Methods Clin Dev | 2022 | 36381305 | PubTator, text mining | PubMed |
| Brazilian Red Propolis Presents Promising Anti-H. pylori Activity in In Vitro and In Vivo Assays with the Ability to Modulate the Immune Response. | Molecules | 2022 | 36364137 | PubTator, text mining | PubMed |
| Costimulatory CD226 Signaling Regulates Proliferation of Memory-like NK Cells in Healthy Individuals with Latent Mycobacterium tuberculosis Infection. | Int J Mol Sci | 2022 | 36361628 | PubTator, text mining | PubMed |
| The Role of Epigenetics in the Development and Progression of Multiple Myeloma. | Biomedicines | 2022 | 36359286 | PubTator, text mining | PubMed |
| Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome. | Biomedicines | 2022 | 36359256 | PubTator, text mining | PubMed |
| HCLC-FC: A novel statistical method for phenome-wide association studies. | PLoS One | 2022 | 36350801 | PubTator, text mining | PubMed |
| NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes. | JCI Insight | 2022 | 36346670 | PubTator, text mining | PubMed |
| Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients. | Front Oncol | 2022 | 36338749 | PubTator, text mining | PubMed |
| The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. | Front Oncol | 2022 | 36338731 | PubTator, text mining | PubMed |
| Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions. | Explor Target Antitumor Ther | 2022 | 36338519 | PubTator, text mining | PubMed |
| Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands. | Oncoimmunology | 2022 | 36338147 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment. | Hemasphere | 2022 | 36325271 | PubTator, text mining | PubMed |
| NK cells and solid tumors: therapeutic potential and persisting obstacles. | Mol Cancer | 2022 | 36319998 | PubTator, text mining | PubMed |
A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment. | Front Immunol | 2022 | 36311770 | PubTator, text mining | PubMed |
| Natural killer cell immunotherapy in glioblastoma. | Discov Oncol | 2022 | 36305981 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=30